Generate Biomedicines (GENB): Director filed to sell ~$185K
ARNOLD FRANCES, Director at Generate Biomedicines, filed to sell ~$185K of Generate Biomedicines shares.
- ~$185K
- planned to sell · 11K shares, around Oct 29, 2026
- Planned for
- Oct 29, 2026
- Notice filed
- Oct 29, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Generate Biomedicines
For Generate Biomedicines, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GENB page.
How this filing works
Explore the data
Common questions
Which Generate Biomedicines (GENB) insider traded, and how much?
ARNOLD FRANCES, Director at Generate Biomedicines, filed to sell ~$185K of Generate Biomedicines shares. 11K shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Oct 29, 2026. Notice filed: Oct 29, 2026.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Generate Biomedicines recently?
For Generate Biomedicines, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the GENB page.
Does this mean GENB stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Generate Biomedicines
- SEC Form 13F-HRNov 13, 2026
- SEC Schedule 13GNov 5, 2026
- SEC Form 4Nov 4, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 14, 2026
Everything OQRO holds on this company is on its GENB page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data